Adrian Leo Lopresti (Adrian L Lopresti, Adrian Lopresti)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 13

Top Topics

Systematic Review

Depressive Symptoms

Top Venues

Nutritional neuroscience

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

American journal of men's health

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen James Smith, Adrian Leo Lopresti, Timothy John Fairchild
The effects of alcohol on testosterone synthesis in men: a review. Expert review of endocrinology & metabolism (2023)
Adrian Leo Lopresti, Stephen James Smith
An examination into the mental and physical effects of a saffron extract (affron®) in recreationally-active adults: A randomized, double-blind, placebo-controlled study. Journal of the International Society of Sports Nutrition 19 (1) (2022)
Adrian Leo Lopresti
Potential Role of Curcumin for the Treatment of Major Depressive Disorder. CNS drugs 36 (2) (2022)
Jerome Sarris, Arun Ravindran, Lakshmi N Yatham, Wolfgang Marx, Julia J Rucklidge, Roger S McIntyre, Shahin Akhondzadeh, Francesco Benedetti, Constanza Caneo, Holger Cramer, Lachlan Cribb, Michael de Manincor, Olivia M Dean, Andréa Camaz Deslandes, Marlene P Freeman, Bangalore N Gangadhar, Brian Herbert Harvey, Siegfried Kasper, James Lake, Adrian Leo Lopresti, Lin Lu, Najwa-Joelle Metri, David Mischoulon, Chee H Ng, Daisuke Nishi, Roja Rahimi, Soraya Seedat, Justin Sinclair, Wen-Pang Su, Zhang-Jin Zhang, Michael Berk
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 23 (6) (2022)
Adrian Leo Lopresti, Stephen J Smith, Peter D Drummond
Modulation of the hypothalamic-pituitary-adrenal (HPA) axis by plants and phytonutrients: a systematic review of human trials. Nutritional neuroscience (2021)
Adrian Leo Lopresti, Stephen J Smith, Alexandra P Metse, Tiffany Foster, Peter D Drummond
The Feasibility and Efficacy of a Brief Integrative Treatment for Adults With Depression and/or Anxiety: A Randomized Controlled Trial. Journal of evidence-based integrative medicine 25 (2021)
Adrian Leo Lopresti, Stephen J Smith, Alethea Rea, Shavon Michel
Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study. BMC complementary medicine and therapies 21 (1) (2021)
Adrian Leo Lopresti, Peter D Drummond, Stephen J Smith
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males. American journal of men's health 13 (2) (2020)
Adrian Leo Lopresti, Stephen J Smith, Peter D Drummond
Herbal treatments for migraine: A systematic review of randomised-controlled studies. Phytotherapy research : PTR 34 (10) (2020)
Adrian Leo Lopresti, Stephen J Smith, Sean D Hood, Peter D Drummond
Efficacy of a standardised saffron extract (affron®) as an add-on to antidepressant medication for the treatment of persistent depressive symptoms in adults: A randomised, double-blind, placebo-controlled study. Journal of psychopharmacology (Oxford, England) 33 (11) (2019)
Adrian Leo Lopresti, Hemant Gupta, Stephen J Smith
A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study. BMC complementary and alternative medicine 18 (1) (2018)
Adrian Leo Lopresti
Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects. Drugs in R&D 17 (1) (2017)
Adrian Leo Lopresti
Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies. Attention deficit and hyperactivity disorders 7 (4) (2015)